or
forgot password
  • cancer clinical trials in stanford, CA

  • MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer
    Stanford Advanced Medical Center
    Stanford, California 94305-5826
    Prostate Cancer
    Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants
    Stanford Hospital and Clinics
    Stanford, California 94305
    Lymphoma, Infection, Leukemia
    Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Multiple Myeloma, Plasma Cell Neoplasm
    Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma
    Stanford Hospital and Clinics
    Stanford, California 94305
    Hepatocellular Carcinoma, Liver Cancer
    Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
    Stanford Medical Center
    Stanford, California 94303
    Acute Myeloid Leukemia
    Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
    Stanford Comprehensive Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Kidney Cancer, Leukemia, Lymphoma, Neuroblastoma, Oral Complications, Sarcoma
    A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Renal Cell Carcinoma, Metastases
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Neuroblastoma
    Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Leukemia
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Stanford Cancer Center
    Stanford, California 94305-5824
    Brain Tumor, Central Nervous System Tumor
    Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors
    Stanford University Medical Center
    Stanford, California 94305-5408
    Cancer
    XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
    Stanford University Medical Center
    Stanford, California 94305-5408
    Brain Edema, Brain Tumor
    Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Lymphoma
    Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
    Stanford Cancer Center
    Stanford, California 94305-5824
    Cancer
    Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy
    Stanford University Medical Center
    Stanford, California 94305-5408
    Impotence, Prostate Cancer
    Levocarnitine in Treating Fatigue in Cancer Patients
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.
    Stanford University Medical Center
    Stanford, California 94305-5408
    Neoplasms
    Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Head and Neck Neoplasms
    Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors
    Stanford University Medical Center
    Stanford, California 94305-5408
    Neoplasms
    Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Carcinoma, Renal Cell
    Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
    Stanford Hospital and Clinics
    Stanford, California 94305
    Recurrent Grades 1-3 Follicular Lymphoma, Follicular Lymphoma
    Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
    Stanford University
    Stanford, California 94305
    Large Cell Lymphoma
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Brain and Central Nervous System Tumors
    A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma
    Stanford University
    Stanford, California 94305
    Non-Hodgkin Lymphoma
    Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Lymphoma
    A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)
    Stanford Comprehensive Cancer Center
    Stanford, California 94305
    Cutaneous T-cell Lymphoma
    Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Brain and Central Nervous System Tumors, Unspecified Childhood Solid Tumor, Protocol Specific
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Brain and Central Nervous System Tumors
    Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
    Stanford University Medical Center-Cancer Center
    Stanford, California 94305
    Prostate Cancer
    Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients
    Stanford University Medical Center
    Stanford, California 94305-5408
    Myelodysplastic Syndromes, Iron Overload
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Stanford Comprehensive Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Breast Cancer
    Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab
    Stanford University Medical Center, Division of Hematology
    Stanford, California 94305-5112
    Hemoglobinuria, Paroxysmal
    Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Stanford University Medical Center, Division of Hematology
    Stanford, California 94305-5112
    Paroxysmal Hemoglobinuria, Nocturnal
    Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
    Stanford University Medical Center, Division of Hematology
    Stanford, California 94305-5112
    Hemoglobinuria, Paroxysmal
    Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
    Stanford University Medical Center
    Stanford, California 94305-5408
    Mycosis Fungoides, Sezary Syndrome
    Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
    Stanford University Medical Center
    Stanford, California 94305-5408
    Leukemia, Myelocytic, Acute
    Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
    Stanford Cancer Center
    Stanford, California 94305-5824
    Brain and Central Nervous System Tumors, Unspecified Childhood Solid Tumor, Protocol Specific
    Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides
    Stanford University Medical Center
    Stanford, California 94305-5408
    Mycosis Fungoides
    Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)
    Stanford University Medical Center
    Stanford, California 94305-5408
    Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
    Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Lymphocytic, Acute, Leukemia, Leukemia Acute Promyelocytic Leukemia (APL), Leukemia Acute Lymphoid Leukemia (ALL), Leukemia Chronic Myelogenous Leukemia (CML), Leukemia Acute Myeloid Leukemia (AML), Leukemia Chronic Lymphocytic Leukemia (CLL)
    Phase I/II PTK787/ZK 222584 and Gemcitabine in Advanced Pancreatic Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Pancreatic Cancer
    Mixed Chimera Allo Transplantation in Multiple Myeloma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Blood Cancer, Multiple Myeloma
    Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Multiple Myeloma
    Cyberknife Precision Radiation Delivery System for Tumors of the Spine
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Spinal Cord Cancer, Brain (Nervous System) Cancers
    Haploid Allogeneic Transplant Using the CliniMACS System
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Lymphoma
    Allogeneic Transplantation From Related Haploidentical Donors in Older Patients With Indolent Hematologic Malignancies
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Blood Cancer, Leukemia
    Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer, Carcinoma, Squamous Cell
    Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Brain Cancer
    Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Liver Cancer
    Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lung Cancer
    Phase I/II CPG 7909 + Local XRT in Recurrent Low-Grade Lymphomas
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin
    A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer
    Stanford University Cancer Center
    Stanford, California 94305
    Prostate Cancer
    Alternative Support for Rural and Isolated Women in an HMO
    Stanford University
    Stanford, California 94305
    Stress Disorders, Post-traumatic, Depression, Breast Cancer
    Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Blood Cancer, Blood and Marrow Transplant (BMT)
    High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Multiple Myeloma
    High Dose Chemotherapy Followed By PBSC Rescue for HD
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Hodgkin Disease
    Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Bladder Cancer
    Allo BMT in Advanced Leukemia or High Grade Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin, Leukemia, Blood and Marrow Transplant (BMT), Lymphomas: Non-Hodgkin
    Transplantation for Patients With Chronic Lymphocytic Leukemia
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Lymphocytic, Chronic
    Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Multiple Myeloma
    Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Acute Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Myeloproliferative Disorders, Blood and Marrow Transplant (BMT), Myelodysplastic Syndromes (MDS), Leukemia
    Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin
    Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Myelocytic, Acute, Leukemia, Blood and Marrow Transplant (BMT)
    High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin, Blood and Marrow Transplant (BMT), Lymphomas: Non-Hodgkin
    Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation
    Stanford University Cancer Center
    Stanford, California 94305
    Prostate Cancer
    A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Mouth Cancer, Lip Cancer, Throat Cancer, Lip Neoplasms, Head and Neck Cancers
    Intervention to Decrease Anxiety in Parents of Infants in the Neonatal Intensive Care Unit (NICU)
    Stanford University
    Stanford, California 94305
    Anxiety, Acute Stress Disorder, Posttraumatic Stress Disorder, Depression
    Expanding Rural Access: Distance Delivery of Support
    Stanford University
    Stanford, California 94305
    Breast Cancer, Stress Disorders, Post-Traumatic, Depression